19 news items
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma
REGN
16 Jun 24
, or otherwise. Regeneron uses its media and investor relations website and social media outlets to publish important information about
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
REGN
11 Jun 24
and social responsibility at the center of our ambitions. Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY Regeneron Forward
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
REGN
31 May 24
globally, while putting sustainability and social responsibility at the center of our ambitions. Sanofi is listed on EURONEXT: SAN
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
REGN
31 May 24
treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation
REGN
31 May 24
options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center
9gl126wklhk4xuv1w370f2hojzd9bblduvg56g4sjzw903m2tw5i7ch2u
REGN
31 May 24
vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Sanofi
ngk80cid8aetbzhkhtjzafh4hffskbua67a4knegjiimfy1u
REGN
23 May 24
.Regeneron uses its media and investor relations website and social media outlets to publish important information about the Company
2qpunef1xk ow96nlvi5n1cmsf1d3hl08s950dl1dsqqd3sasdsu5
REGN
20 May 24
options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our
1ujgsi
REGN
20 May 24
globally, while putting sustainability and social responsibility at the center of our ambitions. Sanofi is listed on EURONEXT: SAN
sa9qw1igig6j
REGN
17 May 24
Behavioral and Social Sciences, sponsored by Society for Science
0jcznwbc6gye89z78ks1yg37sh5lq54w3vkng697vaz58g4zschqwrk6ebu8
REGN
17 May 24
Behavioral and Social Sciences, sponsored by Society for Science
ltp0xbwyevxvhc5 j94v
REGN
17 May 24
by Society for ScienceMaddux Alexander Springer, Honolulu, Hawaii Behavioral and Social Sciences, sponsored by Society
xhgt21kr77khyvmo2mcncj2ol3sevj3rbgx83vbcl3n0rz3r89uujlsxgrwa
REGN
13 May 24
and social responsibility at the center of our ambitions. Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY. Regeneron Forward
clm7uc0xsmkisw3da5ii1xmn1wo05a8f11evli 2jvaucwuqasp19sa1dqk
REGN
8 May 24
. Regeneron uses its media and investor relations website and social media outlets to publish important information about the Company, including
gxooney5dql 8j7c
REGN
2 May 24
and investor relations website and social media outlets to publish important information about the Company, including information that may be deemed material
r8c96zhlnj3myfvjhm4t2brokgqblxm1e kns7qy01lt7
REGN
29 Apr 24
. Regeneron uses its media and investor relations website and social media outlets to publish important information about the Company
fjuob0wm2s8n mr3
REGN
22 Apr 24
as a result of new information, future events, or otherwise. Regeneron uses its media and investor relations website and social
7acjajebs5
REGN
7 Apr 24
. Regeneron uses its media and investor relations website and social media outlets to publish important information about the Company, including information
hqpe2
REGN
25 Mar 24
its media and investor relations website and social media outlets to publish important information about the Company, including information that may
- Prev
- 1
- Next